Status:
UNKNOWN
Exploring the Effects of Caltrate Supplement on the Chronic Course of Crohn's Disease Patients With Vitamin D Deficiency
Lead Sponsor:
Second Affiliated Hospital of Wenzhou Medical University
Conditions:
Crohn's Disease
Vitamin D Deficiency
Eligibility:
All Genders
Phase:
EARLY_PHASE1
Brief Summary
Aims:Prospectively observe the effects of Caltrate supplementation on the chronic course of Crohn's disease patients, analyze whether the effect of Caltrate on CD patients is affected by factors such ...
Detailed Description
1. The research can be started only after approval by the Medical Ethics Committee of the Second Affiliated Hospital of Wenzhou Medical University. 2. According to the "Consensus on Diagnosis and Trea...
Eligibility Criteria
Inclusion
- Clearly diagnosed patients with CD
- Vitamin D deficiency (\<= 20ng / ml)
Exclusion
- Pregnancy, lactation
- Liver and kidney insufficiency
- Co-morbid with other autoimmune diseases
- Use antiepileptic drugs or drugs metabolized by liver cytochrome P450 enzymes
- Vitamin D level is normal or high
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04276636
Start Date
October 1 2020
End Date
March 1 2021
Last Update
October 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SAHWenzhouMU
Wenzhou, Zhejiang, China, 325000